Hantavirus infection overview: Difference between revisions
Usama Talib (talk | contribs) |
m (Bot: Removing from Primary care) |
||
| (21 intermediate revisions by 5 users not shown) | |||
| Line 2: | Line 2: | ||
{{Hantavirus infection}} | {{Hantavirus infection}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{USAMA}} | ||
==Overview== | ==Overview== | ||
Hantavirus | Hantavirus infection is a zoonotic disease transmitted by rodents and caused by [[Hantavirus|hantaviruses]] belonging to '''[[bunyaviridae]]''' family. The symptoms of hantavirus infection may include sudden [[fever]], [[prostration]], [[myalgia]]<nowiki/>s, and [[abdominal discomfort]]. [[Pulmonary]] and [[hemorrhagic]] symptoms may also arise in severe disease. The three major clinical entities caused by [[huntavirus|hantaviruses]] include hantavirus cardiopulmonary syndrome ('''HCPS'''), hemorrhagic fever with renal syndrome ('''HFRS)''' and nephropathia epidemica ('''NE'''). Diagnosis of hantavirus infection is usually made by a positive serological test result. Evidence of viral [[antigen]] in tissue by [[immunohistochemistry]], or the presence of amplifiable viral RNA sequences in blood or tissue, with a compatible history of HPS, is considered diagnostic for HPS. Hantavirus infection must be differentiated from other disease based on hemorrhagic fever such as [[dengue]], [[malaria]] and [[Ebola]] and based on the cardiopulmonary involvement such as seen in [[histoplasmosis]], [[coccidioidomycosis]], [[brucellosis]], [[tuberculosis]] and [[aspergillosis]]. The most potent risk factor in the development of hantavirus infection is the exposure to rodent excreta and close contact with hantavirus-infected humans. If left untreated hantavirus infection may cause multiple organ failure and death. The overall prognosis of hantavirus infection depends on the typer of clinical syndrome. The hantavirus cardiopulmonary syndrome (HCPS) has 38% mortality rate. Depending upon which virus is causing the HFRS, death occurs in less than 1% to as many as 15% of the patients. There is no specific treatment, cure, or vaccine for hantavirus infection. However infected individuals who are recognized early and receive medical care in an [[intensive care unit]], may do better. Prevention of hantavirus infection includes indoor and outdoor measures. | ||
==Historical Perspective== | ==Historical Perspective== | ||
HFRS was first clinically recognized in northeast China in1931. In 1976, Lee isolated the first pathogenic hantavirus along the Hantaan River, in South Korea and named it the hantaan virus (HTNV) in1978.<ref name="pmid23607444">{{cite journal |vauthors=Watson DC, Sargianou M, Papa A, Chra P, Starakis I, Panos G |title=Epidemiology of Hantavirus infections in humans: a comprehensive, global overview |journal=Crit. Rev. Microbiol. |volume=40 |issue=3 |pages=261–72 |year=2014 |pmid=23607444 |doi=10.3109/1040841X.2013.783555 |url=}}</ref> | |||
==Classification== | ==Classification== | ||
Hantavirus infection can be classified on the basis of the clinical manifestations and the type of hantavirus responsible for the manifestation. The clinical manifestations may include hantavirus cardiopulmonary syndrome (HCPS), hemorrhagic fever with renal syndrome (HFRS) and nephropathia epidemica (NE).<ref name="pmid28120221">{{cite journal| author=Jiang H, Zheng X, Wang L, Du H, Wang P, Bai X| title=Hantavirus infection: a global zoonotic challenge. | journal=Virol Sin | year= 2017 | volume= 32 | issue= 1 | pages= 32-43 | pmid=28120221 | doi=10.1007/s12250-016-3899-x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28120221 }}</ref> | Hantavirus infection can be classified on the basis of the clinical manifestations and the type of hantavirus responsible for the manifestation. The clinical manifestations may include hantavirus cardiopulmonary syndrome (HCPS), [[hemorrhagic fever]] with renal syndrome (HFRS) and [[nephropathia epidemica]] (NE).<ref name="pmid28120221">{{cite journal| author=Jiang H, Zheng X, Wang L, Du H, Wang P, Bai X| title=Hantavirus infection: a global zoonotic challenge. | journal=Virol Sin | year= 2017 | volume= 32 | issue= 1 | pages= 32-43 | pmid=28120221 | doi=10.1007/s12250-016-3899-x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28120221 }}</ref> | ||
==Pathophysiology== | ==Pathophysiology== | ||
[[Hantavirus]] is usually transmitted via the inhalation of aerosolized viral antigens or rodent bites. The incubation period of hantavirus infection is of 9 to 33 days. Following inhalation, the virus replicates in pulmonary macrophages and dendritic cells. The primary target cells of hantavirus infection are endothelial cells of capillaries. Infection is followed by impairment of the barrier function of endothelial cells, fluid extravasation, and subsequent organ failure. | [[Hantavirus]] is usually transmitted via the inhalation of aerosolized viral antigens or [[rodent]] bites. The incubation period of hantavirus infection is of 9 to 33 days. Following inhalation, the virus replicates in pulmonary macrophages and [[dendritic cells]]. The primary target cells of hantavirus infection are endothelial cells of capillaries. Infection is followed by impairment of the barrier function of endothelial cells, fluid extravasation, and subsequent organ failure. | ||
==Causes== | ==Causes== | ||
Hantaviruses belong to the bunyaviridae family of viruses. There are 5 genera within the bunyaviridae family: bunyavirus, phlebovirus, nairovirus, tospovirus, and hantavirus. Each is made up of negative-sensed, single-stranded RNA viruses. All these genera include arthropod-borne viruses, with the exception of hantavirus, which is a genus of rodent-borne agents. | Hantaviruses belong to the [[bunyaviridae]] family of viruses. There are 5 genera within the bunyaviridae family: [[bunyavirus]], [[phlebovirus]], [[nairovirus]], [[tospovirus]], and [[hantavirus]]. Each is made up of negative-sensed, single-stranded RNA viruses. All these genera include [[arthropod]]-borne viruses, with the exception of hantavirus, which is a genus of [[rodent]]-borne agents. | ||
==Differentiating Hantavirus from other Diseases== | ==Differentiating Hantavirus from other Diseases== | ||
Hemorrhagic fever caused by hantavirus can be differentiated from other disease such as [[dengue]], [[malaria]] and [[Ebola]]. The hantavirus cardiopulmonary syndrome can be differentiated from other diseases like [[histoplasmosis]], [[coccidioidomycosis]], [[brucellosis]], [[tuberculosis]] and [[aspergillosis]]. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Hantavirus infection has a diverse epidemiology and demographics due to the vast number of viruses classified under hantaviruses. The total number of hantavirus pulmonary syndrome (HPS) cases reported in the United States from 2004-2015 is 323. HPS cases have been reported in 30 states, including most of the western half of the country and some eastern states as well. Over half of the confirmed cases have been reported from areas outside the Four Corners area. The mean age of confirmed HPS cases is 38 years (range: 5 to 84 years).<ref name="urlHantavirus Pulmonary Syndrome (HPS) Cases, by State of Exposure | Hantavirus | DHCPP | CDC">{{cite web |url=https://www.cdc.gov/hantavirus/surveillance/state-of-exposure.html |title=Hantavirus Pulmonary Syndrome (HPS) Cases, by State of Exposure | Hantavirus | DHCPP | CDC |format= |work= |accessdate=}}</ref> | Hantavirus infection has a diverse epidemiology and demographics due to the vast number of viruses classified under hantaviruses. The total number of hantavirus pulmonary syndrome (HPS) cases reported in the United States from 2004-2015 is 323. HPS cases have been reported in 30 states, including most of the western half of the country and some eastern states as well. Over half of the confirmed cases have been reported from areas outside the Four Corners area. The mean age of confirmed HPS cases is 38 years (range: 5 to 84 years).<ref name="urlHantavirus Pulmonary Syndrome (HPS) Cases, by State of Exposure | Hantavirus | DHCPP | CDC">{{cite web |url=https://www.cdc.gov/hantavirus/surveillance/state-of-exposure.html |title=Hantavirus Pulmonary Syndrome (HPS) Cases, by State of Exposure | Hantavirus | DHCPP | CDC |format= |work= |accessdate=}}</ref> | ||
==Risk Factors== | ==Risk Factors== | ||
The most potent risk factor in the development of hantavirus infection risk factors is exposure to [[rodent]] excreta and close contact with hantavirus-infected humans.<ref name="pmid23607444">{{cite journal |vauthors=Watson DC, Sargianou M, Papa A, Chra P, Starakis I, Panos G |title=Epidemiology of Hantavirus infections in humans: a comprehensive, global overview |journal=Crit. Rev. Microbiol. |volume=40 |issue=3 |pages=261–72 |year=2014 |pmid=23607444 |doi=10.3109/1040841X.2013.783555 |url=}}</ref> | |||
==Screening== | ==Screening== | ||
There are no screening recommendations for hantavirus infection. | There are no screening recommendations for hantavirus infection. | ||
| Line 31: | Line 35: | ||
==Diagnosis== | ==Diagnosis== | ||
===History and Symptoms=== | ===History and Symptoms=== | ||
The symptoms of hantavirus infection may include sudden fever, prostration, myalgia, and abdominal discomfort. Pulmonary and hemorrhagic symptoms may also arise in severe disease. | The symptoms of hantavirus infection may include sudden [[fever]], [[prostration]], [[myalgia]], and [[abdominal discomfort]]. [[Pulmonary]] and [[hemorrhagic]] symptoms may also arise in severe disease. | ||
===Physical Examination=== | ===Physical Examination=== | ||
Patients with hantavirus infection usually exhibit prostration. Physical examination of patients with hantavirus infection is remarkable for abdominal discomfort, fever, skin petechia, low blood pressure and abnormal cardiopulmonary examination.<ref name="pmid28120221">{{cite journal |vauthors=Jiang H, Zheng X, Wang L, Du H, Wang P, Bai X |title=Hantavirus infection: a global zoonotic challenge |journal=Virol Sin |volume=32 |issue=1 |pages=32–43 |year=2017 |pmid=28120221 |doi=10.1007/s12250-016-3899-x |url=}}</ref><ref name="pmid26461998">{{cite journal |vauthors=Imazio M, Gaita F, LeWinter M |title=Evaluation and Treatment of Pericarditis: A Systematic Review |journal=JAMA |volume=314 |issue=14 |pages=1498–506 |year=2015 |pmid=26461998 |doi=10.1001/jama.2015.12763 |url=}}</ref> | Patients with hantavirus infection usually exhibit prostration. Physical examination of patients with hantavirus infection is remarkable for abdominal discomfort, [[fever]], skin [[petechia]], low blood pressure and abnormal cardiopulmonary examination.<ref name="pmid28120221">{{cite journal |vauthors=Jiang H, Zheng X, Wang L, Du H, Wang P, Bai X |title=Hantavirus infection: a global zoonotic challenge |journal=Virol Sin |volume=32 |issue=1 |pages=32–43 |year=2017 |pmid=28120221 |doi=10.1007/s12250-016-3899-x |url=}}</ref><ref name="pmid26461998">{{cite journal |vauthors=Imazio M, Gaita F, LeWinter M |title=Evaluation and Treatment of Pericarditis: A Systematic Review |journal=JAMA |volume=314 |issue=14 |pages=1498–506 |year=2015 |pmid=26461998 |doi=10.1001/jama.2015.12763 |url=}}</ref> | ||
===Laboratory Findings=== | ===Laboratory Findings=== | ||
| Line 40: | Line 44: | ||
===X ray=== | ===X ray=== | ||
On x-ray, hantavirus infection may manifest as noncardiogenic pulmonary edema is characterized by alveolar infiltrates. | On x-ray, hantavirus infection may manifest as noncardiogenic [[pulmonary edema]] is characterized by [[alveolar]] infiltrates. | ||
===CT scan=== | ===CT scan=== | ||
| Line 46: | Line 50: | ||
===MRI=== | ===MRI=== | ||
There are no MRI findings associated with hantavirus infection. | |||
===Ultrasound=== | ===Ultrasound=== | ||
On renal ultrasound, hantavirus hemorrhagic fever with the renal syndrome may show parenchymal edema, increased [[echogenicity]], and decreased corticomedullary differentiation. | |||
===Other Imaging findings=== | ===Other Imaging findings=== | ||
There are no other imaging findings associated with hantavirus infection. | |||
===Other Diagnostic Studies=== | ===Other Diagnostic Studies=== | ||
Additional diagnostic findings can include the histopathological analysis of lymph nodes, spleen, and liver but are rarely used. | |||
==Treatment== | ==Treatment== | ||
| Line 56: | Line 66: | ||
===Surgery=== | ===Surgery=== | ||
Surgical intervention is not recommended for the management of the hantavirus infection. | |||
===Primary Prevention=== | ===Primary Prevention=== | ||
| Line 61: | Line 72: | ||
===Secondary Prevention=== | ===Secondary Prevention=== | ||
Secondary preventive measures for hantavirus infection are similar to [[Hantavirus primary prevention|primary prevention]]. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Viral diseases]] | [[Category:Viral diseases]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Emergency mdicine]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
[[Category:Nephrology]] | |||
[[Category:Cardiology]] | |||
[[Category:Pulmonology]] | |||
Latest revision as of 21:57, 29 July 2020
|
Hantavirus infection Microchapters |
|
Patient Information |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hantavirus infection overview On the Web |
|
American Roentgen Ray Society Images of Hantavirus infection overview |
|
Directions to Hospitals Treating Hantavirus pulmonary syndrome |
|
Risk calculators and risk factors for Hantavirus infection overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Usama Talib, BSc, MD [2]
Overview
Hantavirus infection is a zoonotic disease transmitted by rodents and caused by hantaviruses belonging to bunyaviridae family. The symptoms of hantavirus infection may include sudden fever, prostration, myalgias, and abdominal discomfort. Pulmonary and hemorrhagic symptoms may also arise in severe disease. The three major clinical entities caused by hantaviruses include hantavirus cardiopulmonary syndrome (HCPS), hemorrhagic fever with renal syndrome (HFRS) and nephropathia epidemica (NE). Diagnosis of hantavirus infection is usually made by a positive serological test result. Evidence of viral antigen in tissue by immunohistochemistry, or the presence of amplifiable viral RNA sequences in blood or tissue, with a compatible history of HPS, is considered diagnostic for HPS. Hantavirus infection must be differentiated from other disease based on hemorrhagic fever such as dengue, malaria and Ebola and based on the cardiopulmonary involvement such as seen in histoplasmosis, coccidioidomycosis, brucellosis, tuberculosis and aspergillosis. The most potent risk factor in the development of hantavirus infection is the exposure to rodent excreta and close contact with hantavirus-infected humans. If left untreated hantavirus infection may cause multiple organ failure and death. The overall prognosis of hantavirus infection depends on the typer of clinical syndrome. The hantavirus cardiopulmonary syndrome (HCPS) has 38% mortality rate. Depending upon which virus is causing the HFRS, death occurs in less than 1% to as many as 15% of the patients. There is no specific treatment, cure, or vaccine for hantavirus infection. However infected individuals who are recognized early and receive medical care in an intensive care unit, may do better. Prevention of hantavirus infection includes indoor and outdoor measures.
Historical Perspective
HFRS was first clinically recognized in northeast China in1931. In 1976, Lee isolated the first pathogenic hantavirus along the Hantaan River, in South Korea and named it the hantaan virus (HTNV) in1978.[1]
Classification
Hantavirus infection can be classified on the basis of the clinical manifestations and the type of hantavirus responsible for the manifestation. The clinical manifestations may include hantavirus cardiopulmonary syndrome (HCPS), hemorrhagic fever with renal syndrome (HFRS) and nephropathia epidemica (NE).[2]
Pathophysiology
Hantavirus is usually transmitted via the inhalation of aerosolized viral antigens or rodent bites. The incubation period of hantavirus infection is of 9 to 33 days. Following inhalation, the virus replicates in pulmonary macrophages and dendritic cells. The primary target cells of hantavirus infection are endothelial cells of capillaries. Infection is followed by impairment of the barrier function of endothelial cells, fluid extravasation, and subsequent organ failure.
Causes
Hantaviruses belong to the bunyaviridae family of viruses. There are 5 genera within the bunyaviridae family: bunyavirus, phlebovirus, nairovirus, tospovirus, and hantavirus. Each is made up of negative-sensed, single-stranded RNA viruses. All these genera include arthropod-borne viruses, with the exception of hantavirus, which is a genus of rodent-borne agents.
Differentiating Hantavirus from other Diseases
Hemorrhagic fever caused by hantavirus can be differentiated from other disease such as dengue, malaria and Ebola. The hantavirus cardiopulmonary syndrome can be differentiated from other diseases like histoplasmosis, coccidioidomycosis, brucellosis, tuberculosis and aspergillosis.
Epidemiology and Demographics
Hantavirus infection has a diverse epidemiology and demographics due to the vast number of viruses classified under hantaviruses. The total number of hantavirus pulmonary syndrome (HPS) cases reported in the United States from 2004-2015 is 323. HPS cases have been reported in 30 states, including most of the western half of the country and some eastern states as well. Over half of the confirmed cases have been reported from areas outside the Four Corners area. The mean age of confirmed HPS cases is 38 years (range: 5 to 84 years).[3]
Risk Factors
The most potent risk factor in the development of hantavirus infection risk factors is exposure to rodent excreta and close contact with hantavirus-infected humans.[1]
Screening
There are no screening recommendations for hantavirus infection.
Natural History, Complications and Prognosis
If hantavirus infection left untreated, it may result in multi-organ failure and death. Possible complications include, acute encephalomyelitis, Pituitary hemorrhage, Glomerulonephritis, Pulmonary edema, acute respiratory distress syndrome, Disseminated intravascular coagulation, Thrombocytopenia, and shock. Its prognosis depends on the extent of the diseases. The hantavirus cardiopulmonary syndrome (HCPS) has 38% mortality rate but, hemorrhagic fever with renal syndrome (HFRS) has a better prognosis with 1 to 15% mortality rate.[4][5][6]
Diagnosis
History and Symptoms
The symptoms of hantavirus infection may include sudden fever, prostration, myalgia, and abdominal discomfort. Pulmonary and hemorrhagic symptoms may also arise in severe disease.
Physical Examination
Patients with hantavirus infection usually exhibit prostration. Physical examination of patients with hantavirus infection is remarkable for abdominal discomfort, fever, skin petechia, low blood pressure and abnormal cardiopulmonary examination.[2][7]
Laboratory Findings
Diagnosis of hantavirus infection is usually made by a positive serological test result. Evidence of viral antigen in tissue by immunohistochemistry, or the presence of amplifiable viral RNA sequences in blood or tissue, with a compatible history of HPS, is considered diagnostic for HPS.
X ray
On x-ray, hantavirus infection may manifest as noncardiogenic pulmonary edema is characterized by alveolar infiltrates.
CT scan
On CT scan, hantavirus pulmonary syndrome is characterized by ground-glass opacities and interlobular and intralobular septal thickening.
MRI
There are no MRI findings associated with hantavirus infection.
Ultrasound
On renal ultrasound, hantavirus hemorrhagic fever with the renal syndrome may show parenchymal edema, increased echogenicity, and decreased corticomedullary differentiation.
Other Imaging findings
There are no other imaging findings associated with hantavirus infection.
Other Diagnostic Studies
Additional diagnostic findings can include the histopathological analysis of lymph nodes, spleen, and liver but are rarely used.
Treatment
Medical Therapy
There is no specific treatment, cure, or vaccine for hantavirus infection. However, we do know that if infected individuals are recognized early and receive medical care in an intensive care unit, they may do better.
Surgery
Surgical intervention is not recommended for the management of the hantavirus infection.
Primary Prevention
Eliminate or minimize contact with rodents in your home, workplace, or campsite. Seal up holes and gaps in your home or garage. Place traps in and around your home to decrease rodent infestation. Clean up any easy-to-get food. Recent research results show that many people who became ill with HPS developed the disease after having been in frequent contact with rodents and/or their droppings around a home or a workplace. On the other hand, many people who became ill reported that they had not seen rodents or rodent droppings at all. Therefore, if you live in an area where the carrier rodents are known to live, try to keep your home, vacation place, workplace, or campsite clean.
Secondary Prevention
Secondary preventive measures for hantavirus infection are similar to primary prevention.
References
- ↑ 1.0 1.1 Watson DC, Sargianou M, Papa A, Chra P, Starakis I, Panos G (2014). "Epidemiology of Hantavirus infections in humans: a comprehensive, global overview". Crit. Rev. Microbiol. 40 (3): 261–72. doi:10.3109/1040841X.2013.783555. PMID 23607444.
- ↑ 2.0 2.1 Jiang H, Zheng X, Wang L, Du H, Wang P, Bai X (2017). "Hantavirus infection: a global zoonotic challenge". Virol Sin. 32 (1): 32–43. doi:10.1007/s12250-016-3899-x. PMID 28120221.
- ↑ "Hantavirus Pulmonary Syndrome (HPS) Cases, by State of Exposure | Hantavirus | DHCPP | CDC".
- ↑ Crowley MR, Katz RW, Kessler R, Simpson SQ, Levy H, Hallin GW, Cappon J, Krahling JB, Wernly J (1998). "Successful treatment of adults with severe Hantavirus pulmonary syndrome with extracorporeal membrane oxygenation". Crit. Care Med. 26 (2): 409–14. PMID 9468181.
- ↑ Mertz GJ, Hjelle B, Crowley M, Iwamoto G, Tomicic V, Vial PA (2006). "Diagnosis and treatment of new world hantavirus infections". Curr. Opin. Infect. Dis. 19 (5): 437–42. doi:10.1097/01.qco.0000244048.38758.1f. PMID 16940866.
- ↑ Levy H, Simpson SQ (1994). "Hantavirus pulmonary syndrome". Am. J. Respir. Crit. Care Med. 149 (6): 1710–3. doi:10.1164/ajrccm.149.6.8004332. PMID 8004332.
- ↑ Imazio M, Gaita F, LeWinter M (2015). "Evaluation and Treatment of Pericarditis: A Systematic Review". JAMA. 314 (14): 1498–506. doi:10.1001/jama.2015.12763. PMID 26461998.